These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4449012)

  • 21. Aerosols and bronchoconstriction.
    Roberts DJ
    Lancet; 1979 Jan; 1(8107):112-3. PubMed ID: 84124
    [No Abstract]   [Full Text] [Related]  

  • 22. [Study of suspension aerosol preparations].
    Kolesnikov LN; Eĭdel'shteĭn SI
    Farmatsiia; 1974; 23(4):18-22. PubMed ID: 4418986
    [No Abstract]   [Full Text] [Related]  

  • 23. Primary packaging considerations in developing medicines for children: oral liquid and powder for constitution.
    Campbell GA; Vallejo E
    J Pharm Sci; 2015 Jan; 104(1):52-62. PubMed ID: 25393927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Basics of Compounding: Compounding Films.
    Allen LV
    Int J Pharm Compd; 2016; 20(4):298-305. PubMed ID: 28333675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro aqueous fluid-capacity-limited dissolution testing of respirable aerosol drug particles generated from inhaler products.
    Arora D; Shah KA; Halquist MS; Sakagami M
    Pharm Res; 2010 May; 27(5):786-95. PubMed ID: 20229134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Powder inhalation aerosol studies I: Selection of a suitable drug entity for bronchial delivery of new drugs.
    Chowhan ZT; Amaro AA
    J Pharm Sci; 1977 Sep; 66(9):1254-8. PubMed ID: 903861
    [No Abstract]   [Full Text] [Related]  

  • 27. Homogeneity of pharmaceutical dispersed systems.
    Hersey JA; Cook PC
    J Pharm Pharmacol; 1974 Feb; 26(2):126-33. PubMed ID: 4150829
    [No Abstract]   [Full Text] [Related]  

  • 28. Wet or dry inhalers?
    Lancet; 1978 Jan; 1(8055):79-80. PubMed ID: 74573
    [No Abstract]   [Full Text] [Related]  

  • 29. Solid-state nanoparticle coated emulsions for encapsulation and improving the chemical stability of all-trans-retinol.
    Ghouchi-Eskandar N; Simovic S; Prestidge CA
    Int J Pharm; 2012 Feb; 423(2):384-91. PubMed ID: 22210001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pulmonary vaccine delivery.
    Lu D; Hickey AJ
    Expert Rev Vaccines; 2007 Apr; 6(2):213-26. PubMed ID: 17408371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Current problems in the hygiene and toxicology of propellants].
    Liarskiĭ PP; Gleĭberman SE; Volkova AP
    Gig Sanit; 1982; (1):65-9. PubMed ID: 7037556
    [No Abstract]   [Full Text] [Related]  

  • 32. Characterization of starch Pickering emulsions for potential applications in topical formulations.
    Marku D; Wahlgren M; Rayner M; Sjöö M; Timgren A
    Int J Pharm; 2012 May; 428(1-2):1-7. PubMed ID: 22366058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rectal administration of drugs.
    Senior N
    Adv Pharm Sci; 1974; 4():363-435. PubMed ID: 4618035
    [No Abstract]   [Full Text] [Related]  

  • 34. Novel propellant-driven inhalation formulations: engineering polar drug particles with surface-trapped hydrofluoroalkane-philes.
    Wu L; Al-Haydari M; da Rocha SR
    Eur J Pharm Sci; 2008 Feb; 33(2):146-58. PubMed ID: 18083015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toxicology of haloalkane propellants and fire extinguishants.
    Back KC; Van Stee W
    Annu Rev Pharmacol Toxicol; 1977; 17():83-95. PubMed ID: 405921
    [No Abstract]   [Full Text] [Related]  

  • 36. Novel pMDI formulations for pulmonary delivery of proteins.
    Li HY; Seville PC
    Int J Pharm; 2010 Jan; 385(1-2):73-8. PubMed ID: 19854252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Particle Surface Roughness Improves Colloidal Stability of Pressurized Pharmaceutical Suspensions.
    Wang H; Nobes DS; Vehring R
    Pharm Res; 2019 Jan; 36(3):43. PubMed ID: 30701324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is the combination of cellulosic polymers and anionic surfactants a good strategy for ensuring physical stability of BCS Class II drug nanosuspensions?
    Bilgili E; Li M; Afolabi A
    Pharm Dev Technol; 2016; 21(4):499-510. PubMed ID: 25774989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pulmonary drug delivery by powder aerosols.
    Yang MY; Chan JG; Chan HK
    J Control Release; 2014 Nov; 193():228-40. PubMed ID: 24818765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of fine solid-crystal suspension with enhanced solubility, stability, and aerosolization performance for dry powder inhalation.
    Lin L; Quan G; Peng T; Huang Z; Singh V; Lu M; Wu C
    Int J Pharm; 2017 Nov; 533(1):84-92. PubMed ID: 28903066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.